Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/3797
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | M. N. Tillyashayhov, N. E. Atahanova, D. M. Almuradova, N. I. Tursunova and L. T. Gaziev. | - |
dc.date.accessioned | 2022-10-12T13:59:33Z | - |
dc.date.available | 2022-10-12T13:59:33Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 2455-3301 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/3797 | - |
dc.description.abstract | This article analyzes the main clinical, morphological and molecular biological factors that influence the outcome of the disease, and their proportion is determined. Favorable prognosis factors include: lack of lymphovascular invasion, tumor infiltration by lymphocytes, lack of expression of PD-1 / PD-L1, mTOR, VEGF-A and KIT, low proliferation index. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Other | en_US |
dc.subject | Renal cell cancer, immunohistochemistry, prognosis, tumor receptors. | en_US |
dc.title | Renal cell cancer prognostic factors | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
WORLD_JOURNAL_OF_PHARMACEUTICAL_Индия_Статья_с_высоким_Импакт_фактором.pdf | Renal cell cancer prognostic factors | 576.39 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.